Medicine
Klor-con M 1500 mg extended-release tablet
Klor-con M 1500 mg extended-release tablet is a prescription medicine containing Potassium chloride for oral use, marketed by Upsher-Smith Laboratories, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59°…
Key facts
- Active ingredient (INN)
- Potassium chloride
- Brand
- Klor-con M
- Strength
- 1500 mg
- Dosage form
- Extended-release tablet
- Route
- Oral
- Packs
- 100 blister pack, 1000 tablets, 100 tablets and 3 more
- Marketing authorisation holder
- Upsher-Smith Laboratories
- Manufacturers
- Upsher-Smith LaboratoriesCardinal Health
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A12BA01 Potassium chloride
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 18 January 2011
- Identifiers
- RxCUI 1801294, 1801295, 403888 +3DailyMed set ID ee3a1815-7325-4838-9764-fe1db68877b6, b89910f6-4ff5-4a62-8269-696f7c10e4f6NDC 55154-5634, 0245-5319Application ANDA074726
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 blister pack in 1 carton / 1 tablet, extended release in 1 blister pack | 0245-5319-01 | Upsher-Smith Laboratories | 21 June 2019 |
| 1000 tablet, extended release in 1 bottle | 0245-5319-10 | Upsher-Smith Laboratories | 21 June 2019 |
| 100 tablet, extended release in 1 bottle | 0245-5319-11 | Upsher-Smith Laboratories | 21 June 2019 |
| 500 tablet, extended release in 1 bottle | 0245-5319-15 | Upsher-Smith Laboratories | 21 June 2019 |
| 90 tablet, extended release in 1 bottle | 0245-5319-90 | Upsher-Smith Laboratories | 21 June 2019 |
| 10 blister pack in 1 bag / 1 tablet, extended release in 1 blister pack | 55154-5634-0 | Cardinal Health | 21 June 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 25 April 1975 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Potassium chloride 1500 mg extended-release tablet.
Other strengths and forms of Potassium chloride
Clinical summary
Potassium chloride is an osmotic laxative indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. MedsAcross supplies Potassium chloride for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Potassium chlorideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- KLOR-CON prescribing information (Upsher-Smith Laboratories) · U.S. National Library of Medicine, DailyMed
Need Klor-con M 1500 mg extended-release tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.